Cargando…
Bronchiolitis in children: The Saudi initiative of bronchiolitis diagnosis, management, and prevention (SIBRO)
Bronchiolitis is the leading cause of admissions in children less than two years of age. It has been recognized as highly debated for many decades. Despite the abundance of literature and the well-recognized importance of palivizumab in the high risk groups, and despite the existence of numerous, hi...
Autores principales: | Alharbi, Adel S., Alqwaiee, Mansour, Al-Hindi, Mohammed Y, Mosalli, Rafat, Al-Shamrani, Abdullah, Alharbi, Saleh, Yousef, Abdullah, Al Aidaroos, Amal, Alahmadi, Turki, Alshammary, Aisha, Miqdad, Abeer, Said, Yazan, Alnemri, Abdulrahman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073791/ https://www.ncbi.nlm.nih.gov/pubmed/30123331 http://dx.doi.org/10.4103/atm.ATM_60_18 |
Ejemplares similares
-
Bronchiolitis in children: The Saudi initiative of bronchiolitis diagnosis, management, and prevention (SIBRO)
por: Manzoni, Paolo
Publicado: (2018) -
Application of aerosol therapy in respiratory diseases in children: A Saudi expert consensus
por: Alharbi, Adel S., et al.
Publicado: (2021) -
Consensus on the Application of Lung Ultrasound in Pneumonia and Bronchiolitis in Children
por: Jaworska, Joanna, et al.
Publicado: (2020) -
Adverse Drug Reactions (ADRs) of Montelukast in Children
por: Al-Shamrani, Abdullah, et al.
Publicado: (2022) -
Approach to childhood asthma in the era of COVID-19: The official statement endorsed by the Saudi Pediatric Pulmonology Association (SPPA)
por: Al-Shamrani, Abdullah, et al.
Publicado: (2020)